巨噬细胞钙蛋白酶促进动脉粥样硬化进展
作者:
作者单位:

(南华大学衡阳医学院药物药理研究所,湖南省衡阳市421001)

作者简介:

罗仕钰,硕士研究生,研究方向为动脉粥样硬化发病机制,E-mail:1667420841@qq.com。通信作者孙少卫,博士,讲师,硕士研究生导师,研究方向为动脉粥样硬化发病机制,E-mail:sunshaowei2004@aliyun.com。

基金项目:

湖南省自然科学基金资助项目(2016JJ3109、2021JJ30599和2021JJ30623);湖南省大学生创新创业训练计划项目(S202110555320)


Macrophages calpain promotes the progression of atherosclerosis
Author:
Affiliation:

Institute of Pharmacy & Pharmacology, Hengyang Medical School, University of South China, Hengyang, Hunan 421001,China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    动脉粥样硬化(As)是一种脂质驱动的慢性炎症性血管疾病,其发病机制以脂质代谢紊乱和炎症反应为主。钙蛋白酶(calpain)是钙离子依赖性半胱氨酸蛋白酶,研究显示其参与了As的发生发展,特别是存在于巨噬细胞中的Calpain对细胞的脂质代谢和炎症反应均有着重要调节作用。文章就巨噬细胞中Calpain参与As的可能途径及分子机制进行综述,为As的防治提供新的思路。

    Abstract:

    Atherosclerosis (As) is a lipid-driven chronic inflammatory vascular disease, the pathogenesis of which primarily includes lipid metabolism disorders and inflammatory responses. Calpain, a calcium-dependent cysteine protease, has been shown to be involved in the development of As. Especially calpain in macrophages plays an important role in regulating lipid metabolism and inflammatory responses in As. This article reviews the possible pathways and molecular mechanisms of macrophages calpain involvement in As trying to provide new ideas for the prevention and treatment of As.

    参考文献
    [1] 龚勇珍, 孙少卫, 廖端芳.细胞炎症反应与脂质代谢的相互作用及调节.中国动脉硬化杂志, 7,5(6):623-629.GONG Y Z, SUN S W, LIAO D F.Interaction and regulation of cell inflammation and lipid metabolism.Chin J Arterioscler, 7,5(6):623-629.
    [2] 郭明秋, 殷晓捷, 刁殿琰, 等.脂质代谢水平与冠状动脉粥样硬化病变的关系.中国动脉硬化杂志, 1,9(2):149-155.GUO M Q, YIN X J, DIAO D Y, et al.Relationship between the levels of lipid metabolism and coronary atherosclerotic lesions.Chin J Arterioscler, 1,9(2):149-155.
    [3] 董亚兰, 胡德胜.动脉粥样硬化的炎症应答特征及运用.中国动脉硬化杂志, 2,0(4):304-312.DONG Y L, HU D S.Characteristics and application of inflammatory response in atherosclerosis.Chin J Arterioscler, 2,0(4):304-312.
    [4] SPINOZZI S, ALBINI S, BEST H, et al.Calpains for dummies:What you need to know about the calpain family.BiochimBiophys Acta Proteins Proteom, 1,9(5):140616.
    [5] SHAPOVALOV I, HARPER D, GREER P A.Calpain as a therapeutic target in cancer.Expert Opin Ther Targets, 2,6(3):217-231.
    [6] SHAMS R, BANIK N L, HAQUE A.Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease.Prog Mol Biol Transl Sci, 9,7:107-124.
    [7] LIANG L W, LI H L, CAO T, et al.Calpain activation mediates microgravity-induced myocardial abnormalities in mice via p38 and ERK1/2 MAPK pathways.J Biol Chem, 0,5(49):16840-16851.
    [8] HOWATT D A, BALAKRISHNAN A, MOORLEGHEN J J, et al.Leukocyte calpain deficiency reduces angiotensin Ⅱ-induced inflammation and atherosclerosis but not abdominal aortic aneurysms in mice.ArteriosclerThrombVasc Biol, 6,6(5):835-845.
    [9] MIYAZAKI T, TAKETOMI Y, TAKIMOTO M, et al.m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis.Circulation, 1,4(23):2522-2532.
    [10] SUBRAMANIAN V, UCHIDA H A, IJAZ T, et al.Calpain inhibition attenuates angiotensin Ⅱ-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.J Cardiovasc Pharmacol, 2,9(1):66-76.
    [11] DE ANDRADE ROSA I, CORRA S, COSTA M L, et al.The scaffolding protein calpain-3 has multiple distributions in embryonic chick muscle cells and it is essential for the formation of muscle fibers.Tissue Cell, 0,7:101436.
    [12] GOTO S, OZAKI Y, OZAWA F, et al.The investigation of calpain in human placenta with fetal growth restriction.Am J Reprod Immunol, 1,5(1):e13325.
    [13] CUI H X, WANG S L, GUO L P, et al.Expression and effect of Calpain9 gene genetic polymorphism on slaughter indicators and intramuscular fat content in chickens.Poult Sci, 8,7(10):3414-3420.
    [14] GUO X W, ZHANG H, HUANG J Q, et al.PIEZO1 ion channel mediates ionizing radiation-induced pulmonary endothelial cell ferroptosis via Ca2+/calpain/VE-cadherin signaling.Front Mol Biosci, 1,8:725274.
    [15] SAITO M, SUZUKI Y, YANO S, et al.Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cells.J Biochem, 6,0(4):227-232.
    [16] CHENG H P, CHENG Q M, BAO X W, et al.Over-activation of NMDA receptors promotes ABCA1 degradation and foam cell formation.Biochim Biophys Acta Mol Cell Biol Lipids, 0,5(10):158778.
    [17] YANG X Y, YIN M H, YU L, et al.Simvastatin inhibited oxLDL-induced proatherogenic effects through calpain-1-PPARγ-CD36 pathway.Can J Physiol Pharmacol, 6,4(12):1336-1343.
    [18] LIU J X, WANG Q N, WEI Y J, et al.Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.Microvasc Res, 2,0:104276.
    [19] ZHAO J F, CHING L C, HUANG Y C, et al.Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis.Mol Nutr Food Res, 2,6(5):691-701.
    [20] KRUTH H S.Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles.Curr Opin Lipidol, 1,2(5):386-393.
    [21] SINGH R K, HAKA A S, BHARDWAJ P, et al.Dynamic actin reorganization and Vav/Cdc42-dependent actin polymerization promote macrophage aggregated LDL (low-density lipoprotein) uptake and catabolism.Arterioscler Thromb Vasc Biol, 9,9(2):137-149.
    [22] NORTON R L, FREDERICKS G J, HUANG Z, et al.Selenoprotein K regulation of palmitoylation and calpain cleavage of ASAP2 is required for efficient FcγR-mediated phagocytosis.J Leukoc Biol, 7,1(2):439-448.
    [23] MIYAZAKI T, TONAMI K, HATA S, et al.Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing.J Clin Invest, 6,6(9):3417-3432.
    [24] WANG N, CHEN W G, LINSEL-NITSCHKE P, et al.A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by ApoA-Ⅰ.J Clin Invest, 3,1(1):99-107.
    [25] MARTINEZ L O, AGERHOLM-LARSEN B, WANG N, et al.Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-Ⅰ.J Biol Chem, 3,8(39):37368-37374.
    [26] ZHAO J F, SHYUE S K, LEE T S.Excess nitric oxide activates TRPV1-Ca2+-calpain signaling and promotes PEST-dependent degradation of liver X receptor α.Int J Biol Sci, 6,2(1):18-29.
    [27] WANG L M, PALME V, ROTTER S, et al.Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages.Mol Nutr Food Res, 7,1(4):1500960.
    [28] LU R, ISHIKAWA T, TANAKA M M U, et al.Zinc increases ABCA1 by attenuating its clearance through the modulation of calmodulin activity.J Atheroscler Thromb, 1,8(3):261-270.
    [29] PENG H C, TANG J J, ZHAO S P, et al.Inhibition of soluble epoxide hydrolase in macrophages ameliorates the formation of foam cells:role of heme oxygenase-1.Circ J, 9,3(12):2555-2566.
    [30] LIN C Y, LEE T S, CHEN C C, et al.Endothelin-1 exacerbates lipid accumulation by increasing the protein degradation of the ATP-binding cassette transporter G1 in macrophages.J Cell Physiol, 1,6(8):2198-2205.
    [31] TANAKA N, ABE-DOHMAE S, IWAMOTO N, et al.Helical apolipoproteins of high-density lipoprotein enhance phagocytosis by stabilizing ATP-binding cassette transporter A7.J Lipid Res, 0,1(9):2591-2599.
    [32] KOURTZELIS I, HAJISHENGALLIS G, CHAVAKIS T.Phagocytosis of apoptotic cells in resolution of inflammation.Front Immunol, 0,1:553.
    [33] SHUMWAY S D, MAKI M, MIYAMOTO S.The PEST domain of IkappaB alpha is necessary and sufficient for in vitro degradation by mu-calpain.J Biol Chem, 9,4(43):30874-30881.
    [34] YU L, YIN M H, YANG X Y, et al.Calpain inhibitor Ⅰ attenuates atherosclerosis and inflammation in atherosclerotic rats through eNOS/NO/NF-κB pathway.Can J PhysiolPharmacol, 8,6(1):60-67.
    [35] LIN F, PEI L, ZHANG Q, et al.Ox-LDL induces endothelial cell apoptosis and macrophage migration by regulating caveolin-1 phosphorylation.J Cell Physiol, 8,3(10):6683-6692.
    [36] WANG X W, DING Z F, LIN J T, et al.LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains.Biochem Biophys Res Commun, 5,7(1):135-139.
    [37] BANDARU S, ALA C D, SALIMI R Z, et al.Targeting filamin a reduces macrophage activity and atherosclerosis.Circulation, 9,0(1):67-79.
    [38] DKUS L E, YOUSEF M, BNCZI Z.Modulators of calpain activity:inhibitors and activators as potential drugs.Expert Opin Drug Discov, 0,5(4):471-486.
    [39] IBORRA R T, MACHADO-LIMA A, OKUDA L S, et al.AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages.J Diabetes Complications, 8,2(1):1-10.
    [40] HORI N, HAYASHI H, SUGIYAMA Y.Calpain-mediated cleavage negatively regulates the expression level of ABCG1.Atherosclerosis, 1,5(2):383-391.
    引证文献
引用本文

罗仕钰,叶世英,张雅玲,高祎,袁碧晨,孙少卫.巨噬细胞钙蛋白酶促进动脉粥样硬化进展[J].中国动脉硬化杂志,2023,31(5):449~455.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2022-09-13
  • 最后修改日期:2022-10-18
  • 在线发布日期: 2023-05-19